These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9234683

  • 1. tau4/tau c/AF-2 of the thyroid hormone receptor relieves silencing of the retinoic acid receptor silencer core independent of both tau4 activation function and full dissociation of corepressors.
    Baniahmad A, Thormeyer D, Renkawitz R.
    Mol Cell Biol; 1997 Aug; 17(8):4259-71. PubMed ID: 9234683
    [Abstract] [Full Text] [Related]

  • 2. Cell-specific inhibition of retinoic acid receptor-alpha silencing by the AF2/tau c activation domain can be overcome by the corepressor SMRT, but not by N-CoR.
    Baniahmad A, Dressel U, Renkawitz R.
    Mol Endocrinol; 1998 Apr; 12(4):504-12. PubMed ID: 9544986
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
    Tong GX, Jeyakumar M, Tanen MR, Bagchi MK.
    Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
    [Abstract] [Full Text] [Related]

  • 4. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN, Brzostek S, Kim B, Chorev M, Wondisford FE, Hollenberg AN.
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [Abstract] [Full Text] [Related]

  • 5. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
    Tagami T, Lutz WH, Kumar R, Jameson JL.
    Biochem Biophys Res Commun; 1998 Dec 18; 253(2):358-63. PubMed ID: 9878542
    [Abstract] [Full Text] [Related]

  • 6. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
    Li H, Leo C, Schroen DJ, Chen JD.
    Mol Endocrinol; 1997 Dec 18; 11(13):2025-37. PubMed ID: 9415406
    [Abstract] [Full Text] [Related]

  • 7. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation.
    Qi JS, Desai-Yajnik V, Greene ME, Raaka BM, Samuels HH.
    Mol Cell Biol; 1995 Mar 18; 15(3):1817-25. PubMed ID: 7862171
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Corepressor SMRT functions as a coactivator for thyroid hormone receptor T3Ralpha from a negative hormone response element.
    Berghagen H, Ragnhildstveit E, Krogsrud K, Thuestad G, Apriletti J, Saatcioglu F.
    J Biol Chem; 2002 Dec 20; 277(51):49517-22. PubMed ID: 12388540
    [Abstract] [Full Text] [Related]

  • 11. The nuclear corepressors recognize distinct nuclear receptor complexes.
    Cohen RN, Putney A, Wondisford FE, Hollenberg AN.
    Mol Endocrinol; 2000 Jun 20; 14(6):900-14. PubMed ID: 10847591
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Retinoic acid receptors beta and gamma do not repress, but instead activate target gene transcription in both the absence and presence of hormone ligand.
    Hauksdottir H, Farboud B, Privalsky ML.
    Mol Endocrinol; 2003 Mar 20; 17(3):373-85. PubMed ID: 12554770
    [Abstract] [Full Text] [Related]

  • 14. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.
    Seol W, Mahon MJ, Lee YK, Moore DD.
    Mol Endocrinol; 1996 Dec 20; 10(12):1646-55. PubMed ID: 8961273
    [Abstract] [Full Text] [Related]

  • 15. Heterodimeric interaction of the retinoic acid and thyroid hormone receptors in transcriptional regulation on the gamma F-crystallin everted retinoic acid response element.
    Tini M, Tsui LC, Giguère V.
    Mol Endocrinol; 1994 Nov 20; 8(11):1494-506. PubMed ID: 7877618
    [Abstract] [Full Text] [Related]

  • 16. Difference in dominant negative activities between mutant thyroid hormone receptors alpha1 and beta1 with an identical truncation in the extreme carboxyl-terminal tau4 domain.
    Nishiyama K, Andoh S, Kitahara A, Natsume H, Mikami T, Genma R, Nakamura H.
    Mol Cell Endocrinol; 1998 Mar 16; 138(1-2):95-104. PubMed ID: 9685218
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M, Tanen MR, Bagchi MK.
    Mol Endocrinol; 1997 Jun 16; 11(6):755-67. PubMed ID: 9171239
    [Abstract] [Full Text] [Related]

  • 18. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators.
    Huang N, vom Baur E, Garnier JM, Lerouge T, Vonesch JL, Lutz Y, Chambon P, Losson R.
    EMBO J; 1998 Jun 15; 17(12):3398-412. PubMed ID: 9628876
    [Abstract] [Full Text] [Related]

  • 19. The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation.
    Au-Fliegner M, Helmer E, Casanova J, Raaka BM, Samuels HH.
    Mol Cell Biol; 1993 Sep 15; 13(9):5725-37. PubMed ID: 8395010
    [Abstract] [Full Text] [Related]

  • 20. Dynamic inhibition of nuclear receptor activation by corepressor binding.
    Sohn YC, Kim SW, Lee S, Kong YY, Na DS, Lee SK, Lee JW.
    Mol Endocrinol; 2003 Mar 15; 17(3):366-72. PubMed ID: 12554786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.